Author: oncologs.com

Autologous Stem Cell Transplantation Emerges as a Promising Approach for Philadelphia-Negative Acute Lymphoblastic Leukemia in Adults Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph-ALL) represents a challenging hematologic malignancy that demands innovative therapeutic strategies for improved patient outcomes. A groundbreaking retrospective study, recently published in BMC Cancer,

In a groundbreaking development poised to transform the management of dermatologic side effects in cancer therapy, researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have unveiled compelling new clinical trial data demonstrating that LUT014, a

In a groundbreaking development within oncology and immunology, researchers have unveiled a novel prognostic model that leverages inflammation-based biomarkers to predict the outcomes of patients suffering from hepatocellular carcinoma (HCC) who undergo radical hepatectomy. This innovative approach combines the C-reactive protein to albumin ratio (CAR)

In a remarkable advancement poised to refine cancer diagnostics, researchers have unveiled the potent combination of high-frame-rate contrast-enhanced ultrasound (HFR CEUS) with contrast vector imaging (CVI) for the evaluation of superficial lymph node (SLN) lesions. This cutting-edge approach promises more accurate discrimination between benign and

In a landmark study recently published in BMC Cancer, researchers have unveiled pivotal insights into the role of Chordin-like 1 (CHRDL1) across a broad spectrum of cancers, highlighting its critical function in lung adenocarcinoma (LUAD). CHRDL1, a secreted antagonist of bone morphogenetic proteins (BMPs), has

In recent years, the battle against triple-negative breast cancer (TNBC) has intensified as researchers strive to unravel the complex biological pathways underlying this aggressive and notoriously difficult-to-treat cancer variant. A groundbreaking study published in BMC Cancer in 2025 now shines a spotlight on a novel

A groundbreaking study recently published in BMC Cancer sheds new light on the complex interplay between metabolic markers, genetic predisposition, and the risk of developing breast cancer in postmenopausal women. This extensive research conducted using the UK Biobank cohort delves into the association of triglyceride-glucose

In a groundbreaking leap towards revolutionizing medical diagnostics, researchers have unveiled an advanced artificial intelligence (AI) model that promises to transform the way oral epithelial dysplasia is detected and graded. Oral epithelial dysplasia (OED) is a precancerous condition marked by abnormal cellular behavior in the

In a groundbreaking study poised to reshape therapeutic strategies for hepatocellular carcinoma (HCC), researchers have demonstrated the superior efficacy and safety of combining tyrosine kinase inhibitors (TKIs) and programmed cell death protein-1 (PD-1) inhibitors with hepatic arterial infusion chemotherapy (HAIC) or transarterial chemoembolization (TACE) in

University of Cincinnati Cancer Center researchers are poised to unveil a series of groundbreaking findings at the upcoming American Association for Cancer Research Annual Meeting 2025 in Chicago. Focusing predominantly on head and neck cancer (HNC) and other malignancies, their work explores complex molecular mechanisms,